|Articles|August 1, 2000

August 2000
Volume 6
Issue 8

Cost Effectiveness of Rabeprazole Versus Generic Ranitidine for Symptom Resolution in Patients with Erosive Esophagitis

Author(s)Joshua J. Ofman, MD, MSHS, Beverly D. Yamashita, RN, BSN, Reshmi M. Siddique, PhD, MSc

Download PDF: Cost Effectiveness of Rabeprazole Versus Generic Ranitidine for Symptom Resolution in Patients with Erosive Esophagitis

Articles in this issue

about 26 years ago

Article

What Price an Additional Day of Life? A Cost-Effectiveness Study of Case Management

about 26 years ago

Article

Use of Randomized Controlled Trials in Organizational Decision Making: A Cost-Minimization Approach

about 26 years ago

Article

Medicare Disenrollment and Selective Use of Medical Care: Osteoarthritis-Related Joint Replacement

about 26 years ago

Article

The Community Assessment Risk Screen (CARS): Identifying Elderly Persons at Risk for Hospitalization or Emergency Department Visit

about 26 years ago

Article

Proton Pump Inhibitors: Cost-Effective Agents for Management of Reflux-Induced Esophagitis

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Cost Effectiveness of Rabeprazole Versus Generic Ranitidine for Symptom Resolution in Patients with Erosive Esophagitis

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care